News

  • News

    A book co-authored by A2Healthcare employees will be published in 〈ICH E6(R3)/E8(R1)/Revised GCP Guidance〉 QMS Implementation (Issue Management and CAPA Development) in Clinical Trials/Clinical Research and Utilization of QbD in Study Design

  • News

    A paper co-authored by A2Healthcare employees was published in Therapeutic Innovation & Regulatory Science.

  • Exhibition

    Clinical Trials in Oncology East Coast 2024 / Boston

  • Exhibition

    DIA2024 GLOBAL ANNUAL MEETING/SAN DIEGO

  • Company

    Japan’s Premier Clinical CRO A2 Healthcare, an ITOCHU Subsidiary, Launches US Expansion

  • A paper co-authored by A2Healthcare employees was published in Heliyon.

  • News

    A2 Healthcare presented research results at Japan in your Regulatory Strategy Conference.

  • News

    A2 Healthcare present research results at 2023 International Joint Meeting of the 23rd International Conference on Cytochrome P450 and the 38th Annual Meeting of the Japanese Society for the study of Xenobiotics.

  • News

    A2 Healthcare present research results at SCDM Annual Conference 2023.

  • News

    Notice of publication of interview articles

  • News

    Joint Research and Development Agreement on “Human (Allogeneic) Subcutaneous Adipose Tissue-Derived Mesenchymal Stem Cell Sheet (PAL-222) for Patients with Myopic Chorioretinal Atrophy

  • News

    Regarding the Partnership Agreement for Clinical Trials between A2 and NRGJ, a subsidiary of the National Cancer Institute in the United States

  • News

    Exhibit at「DIA Global Annual Meeting 2023 in Boston」

  • News

    Notice of publication of interview articles

  • News

    A paper co-authored by A2 Healthcare employee was published in The Journal of Clinical Pharmacology.